Prenetics Global Limited
General ticker "PRE" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $218.3M (TTM average)
Prenetics Global Limited follows the US Stock Market performance with the rate: 38.0%.
Estimated limits based on current volatility of 3.6%: low 25.80$, high 27.74$
Factors to consider:
- Total employees count: 1158 as of 2022
- Current price 25.0% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.18$, 20.83$]
- 2026-12-31 to 2027-12-31 estimated range: [5.04$, 13.87$]
Financial Metrics affecting the PRE estimates:
- Negative: with PPE of -4.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -9.28 <= 0.28
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.10 <= 0.75
- Negative: Shareholder equity ratio, % of 85.79 > 63.63
Short-term PRE quotes
Long-term PRE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $21.74MM | $30.62MM | $92.39MM |
| Operating Expenses | $73.65MM | $78.77MM | $130.52MM |
| Operating Income | $-51.91MM | $-48.14MM | $-38.13MM |
| Non-Operating Income | $-4.76MM | $-9.56MM | $1.92MM |
| Interest Expense | $0.12MM | $0.20MM | $0.24MM |
| R&D Expense | $11.66MM | $10.92MM | $5.13MM |
| Income(Loss) | $-56.67MM | $-57.70MM | $-36.21MM |
| Taxes | $-0.27MM | $-7.87MM | $0.03MM |
| Net Income(Loss)* | $-62.72MM | $-46.30MM | $-37.71MM |
| Stockholders Equity | $206.36MM | $170.39MM | $174.60MM |
| Inventory | $3.13MM | $6.57MM | $7.06MM |
| Assets | $254.17MM | $213.57MM | $203.52MM |
| Operating Cash Flow | $-13.76MM | $-28.87MM | $-21.81MM |
| Capital expenditure | $0.91MM | $1.06MM | $0.21MM |
| Investing Cash Flow | $-82.95MM | $38.54MM | $-35.79MM |
| Financing Cash Flow | $-4.70MM | $-3.34MM | $37.54MM |
| Earnings Per Share** | $-5.58 | $-3.64 | $-2.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.